Core Insights - Tilray Brands reported a 9% year-over-year increase in net revenue, reaching a record $211 million in Q2, with a 10% increase in constant currency [4][6] - Gross profit rose by 29% year-over-year to $61 million, with gross margin improving to 29% from 24% [4][6] - The company announced Project 420, a $25 million synergy plan aimed at enhancing the Tilray beverage business [5][8] Financial Performance - Beverage revenue increased by 36% to $63 million, while international cannabis revenue grew by 25% and wellness segment revenue rose by 13% [4][6] - Adjusted gross profit increased by 20% to $63 million, with adjusted EBITDA at $9 million [6][8] - The net loss for the quarter was $(85) million, primarily due to non-cash items [6][8] Strategic Initiatives - Project 420 aims to achieve $25 million in synergies through operational optimization, cost savings, and SKU rationalization [5][7] - The company is focusing on brand and business investment to reestablish dominance in core markets, with $17 million of the synergy plan already achieved [8][9] - Tilray is committed to its fiscal year 2025 guidance, anticipating net revenues between $950 million and $1 billion [9][10] Market Position - Tilray is positioned as a leading force in the beverage industry, revitalizing the beer market and advancing cannabis legitimacy for recreational and medical use [3][11] - The company has made several acquisitions in the beverage category to diversify its product offerings and scale its business [5][11] Operational Highlights - The company is optimizing its operational footprint by integrating manufacturing and warehousing assets to improve efficiency [7][8] - SKU rationalization efforts are aimed at focusing resources on higher growth products, which is expected to accelerate revenue growth in future quarters [7][8]

Company Overview - Tilray Brands Inc (NASDAQ: TLRY) is a global lifestyle company that has shifted away from a pure cannabis focus, but its financial performance has not improved [1] Earnings Report - Tilray Brands Inc is set to report earnings at the end of the week, and the results are likely not very promising [1] Investment Research Service - Out Fox The Street is an investing group led by Mark that provides stock picks, deep research, and various model portfolios to help readers uncover potential multibaggers while managing portfolio risk via diversification [1] - The service features daily updates, real-time alerts, and access to community chat and direct chat with Mark for questions [1]

Company Announcement - Tilray Medical, a division of Tilray Brands, Inc, has secured a tender to supply Luxembourg with high-quality cannabis flower through its German subsidiary, Tilray Deutschland GmbH [1] - The tender was granted by the Ministry of Health and Social Security for the Grand Duchy of Luxembourg, highlighting the trust placed in Tilray Medical to deliver consistent, high-quality medical cannabis globally [1] - This achievement reinforces Tilray's commitment to meeting Europe's growing demand for premium medical cannabis products [1] Leadership Statement - Denise Faltischek, Chief Strategy Officer and Head of International, expressed honor in being selected again to supply medical cannabis to Luxembourg, attributing this success to the team's dedication to providing high-quality medical cannabis products to patients worldwide [2] Company Overview - Tilray Medical is dedicated to transforming lives and fostering dignity for patients through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray Medical, Broken Coast, Redecan, Good Supply, and Navcora [2] - The company has grown from being one of the first approved licensed producers of medical cannabis in Canada to building the first GMP-certified cannabis production facilities in Portugal and Germany [2] - Today, Tilray Medical is one of the largest suppliers of medical cannabis brands, serving patients, physicians, hospitals, pharmacies, researchers, and governments in over 20 countries across five continents [2] Parent Company Information - Tilray Brands, Inc is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America [3] - The company operates at the intersection of cannabis, beverage, wellness, and entertainment, aiming to elevate lives through moments of connection [3] - Tilray's mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences [3] - The company supports over 40 brands in more than 20 countries, offering comprehensive cannabis products, hemp-based foods, and craft beverages [3]

Market Performance - Tilray Brands, Inc (TLRY) closed at $1 45 with a -0 68% movement compared to the previous day lagging behind the S&P 500's 1 26% gain the Dow's 0 8% gain and the Nasdaq's 1 77% gain [1] - Over the previous month TLRY shares gained 12 31% outperforming the Consumer Staples sector's loss of 6 03% and the S&P 500's loss of 2 82% [1] Earnings and Revenue Estimates - The company is expected to release earnings on January 10 2025 with a Zacks Consensus Estimate for revenue of $218 22 million up 12 62% from the year-ago period [2] - For the entire fiscal year the Zacks Consensus Estimates predict earnings of -$0 14 per share and revenue of $908 93 million indicating year-over-year changes of +57 58% and +15 21% respectively [3] Analyst Estimate Revisions - Recent changes to analyst estimates for Tilray Brands Inc reflect short-term business trends with positive revisions indicating optimism about the company's business outlook [4] - These estimate alterations are directly linked to near-term stock price performance [5] Industry Ranking - The Consumer Products - Staples industry part of the Consumer Staples sector has a Zacks Industry Rank of 73 placing it in the top 30% of all 250+ industries [6] - The Zacks Industry Rank shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [6] Zacks Rank System - The Zacks Rank system ranges from 1 (Strong Buy) to 5 (Strong Sell) with 1 rated stocks producing an average annual return of +25% since 1988 [7] - Over the past month the Zacks Consensus EPS estimate for Tilray Brands Inc has shifted 2 33% upward and the company currently holds a Zacks Rank of 3 (Hold) [7]

Due to the closure of the Securities and Exchange Commission and U.S. stock markets on January 9, in honor of the late former President Jimmy Carter, Tilray has moved its earnings announcement to January 10NEW YORK and LEAMINGTON, Ontario, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will now release its financial results for the second quarter ende ...

NEW YORK, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer goods company, invites you to celebrate the new year with its refreshing non-alcoholic beverages from Liquid Love, Herb & Bloom, Happy Flower, Runner's High, and Montauk Brewing Company. Liquid Love sparkling water brings triple-filtered hydration with electrolytes and B-vitamins for a crisp and clean experience with environmentally conscious packaging. Plus, five cents is donated to non- ...

Company Overview - Tilray Brands, Inc. is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America [10] - The company aims to be a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, focusing on creating memorable experiences [10] - Tilray supports over 40 brands in more than 20 countries, offering a diverse range of products including cannabis offerings, hemp-based foods, and craft beverages [10] Product Offerings - The company has launched a variety of non-alcoholic beverages, including Liquid Love, Herb & Bloom, Happy Flower, Runner's High, and Montauk Brewing Company [4] - Liquid Love features sparkling beverages in flavors such as grapefruit, lemon-lime, wildberry, and ginger-prickly pear, emphasizing hydration with electrolytes and B-vitamins [23] - Herb & Bloom offers a super-premium line of non-alcoholic cocktails infused with 5mg of hemp-derived Delta-9 THC per can, designed for a relaxing social experience [2][15] - Happy Flower provides a trio of hemp-derived THC cocktails, each containing 5mg of THC, aimed at delivering a refreshing social experience [15] - Montauk Brewing Company's N.A. IPA is a full-flavored non-alcoholic brew crafted to provide the experience of traditional IPAs without the alcohol [18] Social Responsibility - Liquid Love donates five cents to non-profit causes focused on clean water and conservation for each beverage sold, supporting environmental sustainability [23]

Core Insights - The article emphasizes the importance of key quantitative metrics in evaluating a company's performance, particularly focusing on Tilray Brands' return on invested capital (ROIC) [1][2] Financial Performance - Tilray's trailing-12-month (TTM) ROIC is negative 5.5%, with a median ROIC of negative 9.4% over the last three years, indicating a destruction of shareholder value [6] - The company reported operating losses totaling $108.3 million in the TTM period, highlighting its struggle to generate returns above its capital costs [7] Investment Strategy - Tilray is heavily investing in selling, general, and administrative (SG&A) expenses to gain market share, which has led to operational unprofitability despite generating revenue exceeding its cost of goods sold (COGS) [8] - The company competes in saturated markets, including recreational and medicinal marijuana in Canada and North American alcoholic beverages, limiting its competitive advantage [10] Future Outlook - There is potential for Tilray's investments to yield positive ROIC in the future, especially if consumer loyalty develops and market conditions improve, such as potential marijuana legalization in the U.S. [13] - The company is not under immediate financial pressure to achieve profitability, with $287.9 million in long-term debt and $280.1 million in cash and equivalents, allowing it to sustain its expansion efforts [14] Investment Considerations - Investors should be prepared for a long-term hold, as immediate improvements in efficiency and profitability are not expected [15]

It's not a secret: The cannabis industry has been a major disappointment since Canada legalized recreational use in 2018. Some companies in the industry diversified away from their cannabis operations as a result.That was the case with Tilray Brands (TLRY 8.62%), which, through acquisitions, became one of the largest craft brewers in the U.S. But it remains a leader in the Canadian pot market and hopes that the legal landscape in other countries, especially in the U.S., will change.Tilray's CEO, Irwin Simon ...

NEW YORK and LEAMINGTON, Ontario, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will release its financial results for the second quarter ended November 30, 2024 before the financial market opens on January 9, 2025. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 a. ...